Literature DB >> 15329071

Brain blood-flow alterations induced by therapeutic vagus nerve stimulation in partial epilepsy: II. prolonged effects at high and low levels of stimulation.

Thomas R Henry1, Roy A E Bakay, Page B Pennell, Charles M Epstein, John R Votaw.   

Abstract

PURPOSE: To measure vagus nerve stimulation (VNS)-induced cerebral blood flow (CBF) effects after prolonged VNS and to compare these effects with immediate VNS effects on CBF.
METHODS: Ten consenting partial epilepsy patients had positron emission tomography (PET) with intravenous [15O]H2O. Each had three control scans without VNS and three scans during 30 s of VNS, within 20 h after VNS began (immediate-effect study), and repeated after 3 months of VNS (prolonged study). After intrasubject subtraction of control from stimulation scans, images were anatomically transformed for intersubject averaging and superimposed on magnetic resonance imaging (MRI) for anatomic localization. Changes on t-statistical maps were considered significant at p < 0.05 (corrected for multiple comparisons).
RESULTS: During prolonged studies, CBF changes were not observed in any regions that did not have CBF changes during immediate-effect studies. During both types of studies, VNS-induced CBF increases were similarly located in the bilateral thalami, hypothalami, inferior cerebellar hemispheres, and right postcentral gyrus. During immediate-effect studies, VNS decreased bilateral hippocampal, amygdalar, and cingulate CBF and increased bilateral insular CBF; no significant CBF changes were observed in these regions during prolonged studies. Mean seizure frequency decreased by 25% over a 3-month period between immediate and prolonged PET studies, compared with 3 months before VNS began.
CONCLUSIONS: Seizure control improved during a period over which some immediate VNS-induced CBF changes declined (mainly over cortical regions), whereas other VNS-induced CBF changes persisted (mainly over subcortical regions). Altered synaptic activities at sites of persisting VNS-induced CBF changes may reflect antiseizure actions. Copyright 2004 International League Against Epilepsy

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15329071     DOI: 10.1111/j.0013-9580.2004.03104.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  39 in total

Review 1.  Interoceptive dysfunction: toward an integrated framework for understanding somatic and affective disturbance in depression.

Authors:  Christopher Harshaw
Journal:  Psychol Bull       Date:  2014-11-03       Impact factor: 17.737

2.  Comparison of ΔFosB immunoreactivity induced by vagal nerve stimulation with that caused by pharmacologically diverse antidepressants.

Authors:  Havan Furmaga; Mohona Sadhu; Alan Frazer
Journal:  J Pharmacol Exp Ther       Date:  2012-01-27       Impact factor: 4.030

3.  Increased extracellular concentrations of norepinephrine in cortex and hippocampus following vagus nerve stimulation in the rat.

Authors:  Rodney W Roosevelt; Douglas C Smith; Richard W Clough; Robert A Jensen; Ronald A Browning
Journal:  Brain Res       Date:  2006-09-07       Impact factor: 3.252

4.  BOLD fMRI deactivation of limbic and temporal brain structures and mood enhancing effect by transcutaneous vagus nerve stimulation.

Authors:  T Kraus; K Hösl; O Kiess; A Schanze; J Kornhuber; C Forster
Journal:  J Neural Transm (Vienna)       Date:  2007-06-14       Impact factor: 3.575

Review 5.  Lennox-Gastaut syndrome: a comprehensive review.

Authors:  Ali A Asadi-Pooya
Journal:  Neurol Sci       Date:  2017-11-09       Impact factor: 3.307

6.  Pretreatment cerebral metabolic activity correlates with antidepressant efficacy of vagus nerve stimulation in treatment-resistant major depression: a potential marker for response?

Authors:  Charles R Conway; John T Chibnall; Sunil Gangwani; Mark A Mintun; Joseph L Price; Tamara Hershey; Luis A Giuffra; Richard D Bucholz; Jon J Christensen; Yvette I Sheline
Journal:  J Affect Disord       Date:  2012-03-05       Impact factor: 4.839

Review 7.  Vagus nerve stimulation in psychiatry: a systematic review of the available evidence.

Authors:  Camelia-Lucia Cimpianu; Wolfgang Strube; Peter Falkai; Ulrich Palm; Alkomiet Hasan
Journal:  J Neural Transm (Vienna)       Date:  2016-11-16       Impact factor: 3.575

8.  Vagus nerve stimulation to augment recovery from severe traumatic brain injury impeding consciousness: a prospective pilot clinical trial.

Authors:  Chen Shi; Steven R Flanagan; Uzma Samadani
Journal:  Neurol Res       Date:  2013-04       Impact factor: 2.448

9.  Transcutaneous noninvasive vagus nerve stimulation (tVNS) in the treatment of schizophrenia: a bicentric randomized controlled pilot study.

Authors:  Alkomiet Hasan; Claus Wolff-Menzler; Sebastian Pfeiffer; Peter Falkai; Elif Weidinger; Andrea Jobst; Imke Hoell; Berend Malchow; Peyman Yeganeh-Doost; Wolfgang Strube; Silke Quast; Norbert Müller; Thomas Wobrock
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2015-07-26       Impact factor: 5.270

10.  Chronic vagus nerve stimulation for treatment-resistant depression decreases resting ventromedial prefrontal glucose metabolism.

Authors:  José V Pardo; Sohail A Sheikh; Graeme C Schwindt; Joel T Lee; Michael A Kuskowski; Christa Surerus; Scott M Lewis; Faruk S Abuzzahab; David E Adson; Barry R Rittberg
Journal:  Neuroimage       Date:  2008-05-15       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.